President Donald Trump hosted an Oval Office event focused on lowering prescription drug costs, but attention quickly shifted to a 2-year-old boy whose case was presented as a "miracle" breakthrough in treatment. Toddler Travis Smith, who was born deaf, was highlighted as a recipient of a therapy linked to Regeneron Pharmaceuticals. The child later became the center of attention as his behavior during the event drew reactions from those in the room.